Dr. Michelle Scanlan, MD
What this data tells you about Dr. Scanlan
Dr. Michelle Scanlan is an internal medicine specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Scanlan performed 8,534 Medicare services across 5,410 unique beneficiaries.
Between the years covered by Open Payments, Dr. Scanlan received a total of $4,281 from 20 pharmaceutical and/or device companies across 62 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Scanlan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Comprehensive metabolic blood panel | 693 | $10 | $11 |
| Blood draw (venipuncture) | 641 | $3 | $3 |
| Complete blood count (CBC) with differential | 623 | $8 | $8 |
| Thyroid hormone evaluation | 562 | $6 | $6 |
| Thyroid stimulating hormone (TSH) test | 561 | $16 | $17 |
| Lipid panel (cholesterol and triglycerides) | 560 | $13 | $13 |
| Thyroxine (thyroid chemical), total | 560 | $7 | $7 |
| Office visit, established patient (30-39 min) | 559 | $86 | $132 |
| Vitamin D level test | 527 | $29 | $30 |
| Hemoglobin A1c test (diabetes monitoring) | 513 | $10 | $10 |
| Creatine kinase (cardiac enzyme) level, total | 462 | $6 | $7 |
| Office visit, established patient (20-29 min) | 453 | $58 | $94 |
| Creatinine test (kidney function) | 327 | $5 | $5 |
| Urine microalbumin test (kidney screening) | 321 | $6 | $6 |
| Annual wellness visit, follow-up | 258 | $119 | $137 |
| Chest X-ray, 2 views | 91 | $23 | $36 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 78 | $260 | $265 |
| Pneumonia vaccine administration | 76 | $24 | $24 |
| Manual urinalysis test with examination using microscope, non-automated | 72 | $4 | $4 |
| Flu vaccine, high-dose | 69 | $72 | $73 |
| Flu vaccine administration | 65 | $30 | $30 |
| Urine culture, bacterial colony count | 43 | $8 | $8 |
| Electrocardiogram (EKG), 12-lead | 41 | $10 | $15 |
| Iron binding capacity test | 40 | $9 | $9 |
| Ferritin level test (iron stores) | 39 | $13 | $14 |
| Iron level test | 38 | $6 | $6 |
| Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | 33 | $25 | $43 |
| Vitamin B-12 level test | 31 | $15 | $15 |
| Bone density scan (DEXA) | 30 | $35 | $40 |
| Administration of vaccine | 28 | $13 | $19 |
| PSA test (prostate cancer screening) | 26 | $18 | $18 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 22 | $7 | $7 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 18 | $140 | $143 |
| X-ray of paranasal sinus, minimum of 3 views | 14 | $24 | $41 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 14 | $4 | $4 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 12 | $41 | $41 |
| New patient office visit, complex (60-74 min) | 12 | $143 | $228 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $16 | $17 |
| Transitional care management services for problem of high complexity | 11 | $202 | $287 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Scanlan is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement in the top 18% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Scanlan experienced with comprehensive metabolic blood panel?
Does Dr. Scanlan receive payments from pharmaceutical companies?
How do Dr. Scanlan's costs compare to other internal medicine physicians in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology